| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Inflammasomes | 24 | 2025 | 156 | 5.130 |
Why?
|
| Podocytes | 20 | 2025 | 76 | 4.660 |
Why?
|
| NLR Family, Pyrin Domain-Containing 3 Protein | 20 | 2025 | 129 | 2.790 |
Why?
|
| Immediate-Early Proteins | 18 | 2011 | 57 | 2.680 |
Why?
|
| Sphingomyelin Phosphodiesterase | 10 | 2018 | 43 | 2.110 |
Why?
|
| Hyperhomocysteinemia | 13 | 2017 | 37 | 2.070 |
Why?
|
| Kidney Glomerulus | 14 | 2017 | 80 | 2.020 |
Why?
|
| Adipokines | 4 | 2025 | 121 | 1.640 |
Why?
|
| Carrier Proteins | 10 | 2025 | 1024 | 1.450 |
Why?
|
| Nicotine | 2 | 2025 | 117 | 1.440 |
Why?
|
| Nicotinamide Phosphoribosyltransferase | 5 | 2023 | 20 | 1.310 |
Why?
|
| Gene Silencing | 9 | 2016 | 230 | 1.130 |
Why?
|
| Animals | 99 | 2025 | 34321 | 1.060 |
Why?
|
| HMGB1 Protein | 2 | 2024 | 28 | 1.030 |
Why?
|
| Signal Transduction | 24 | 2025 | 4666 | 1.020 |
Why?
|
| Thioredoxins | 2 | 2025 | 27 | 1.020 |
Why?
|
| Mice | 75 | 2025 | 18464 | 1.020 |
Why?
|
| Kidney | 12 | 2017 | 1304 | 0.980 |
Why?
|
| Blood Pressure | 12 | 2017 | 1344 | 0.930 |
Why?
|
| Caspase 1 | 11 | 2025 | 49 | 0.910 |
Why?
|
| Membrane Glycoproteins | 8 | 2017 | 421 | 0.890 |
Why?
|
| Electrolytes | 5 | 2010 | 58 | 0.880 |
Why?
|
| Gene Deletion | 6 | 2018 | 773 | 0.860 |
Why?
|
| Coronary Vessels | 12 | 2018 | 529 | 0.850 |
Why?
|
| Interleukin-1beta | 12 | 2025 | 159 | 0.840 |
Why?
|
| Kidney Diseases | 5 | 2012 | 482 | 0.840 |
Why?
|
| Apoptosis Regulatory Proteins | 8 | 2019 | 165 | 0.820 |
Why?
|
| Sphingolipids | 2 | 2017 | 35 | 0.820 |
Why?
|
| ADP-ribosyl Cyclase 1 | 5 | 2017 | 18 | 0.810 |
Why?
|
| Proto-Oncogene Proteins c-akt | 7 | 2011 | 483 | 0.800 |
Why?
|
| Mice, Knockout | 33 | 2018 | 3860 | 0.770 |
Why?
|
| Ceramides | 8 | 2016 | 46 | 0.710 |
Why?
|
| Lysosomes | 14 | 2018 | 260 | 0.710 |
Why?
|
| Methylamines | 2 | 2019 | 22 | 0.690 |
Why?
|
| NADPH Oxidases | 10 | 2023 | 108 | 0.690 |
Why?
|
| KCNQ1 Potassium Channel | 4 | 2010 | 12 | 0.680 |
Why?
|
| Glycogen Synthase Kinase 3 | 3 | 2011 | 60 | 0.650 |
Why?
|
| Mice, Inbred C57BL | 28 | 2018 | 4761 | 0.620 |
Why?
|
| Polyunsaturated Alkamides | 2 | 2016 | 17 | 0.620 |
Why?
|
| Arachidonic Acids | 2 | 2016 | 17 | 0.620 |
Why?
|
| Endocannabinoids | 2 | 2016 | 29 | 0.610 |
Why?
|
| Endothelial Cells | 9 | 2019 | 536 | 0.600 |
Why?
|
| Sodium Chloride, Dietary | 4 | 2017 | 29 | 0.600 |
Why?
|
| RNA, Small Interfering | 13 | 2018 | 665 | 0.600 |
Why?
|
| Autophagy | 7 | 2018 | 424 | 0.570 |
Why?
|
| Potassium | 7 | 2009 | 270 | 0.570 |
Why?
|
| Epithelial-Mesenchymal Transition | 6 | 2017 | 262 | 0.560 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2019 | 634 | 0.550 |
Why?
|
| Oxidative Stress | 6 | 2017 | 804 | 0.520 |
Why?
|
| Antihypertensive Agents | 5 | 2017 | 422 | 0.520 |
Why?
|
| Cell Line | 10 | 2025 | 2604 | 0.510 |
Why?
|
| Dietary Fats | 2 | 2010 | 276 | 0.510 |
Why?
|
| Cells, Cultured | 18 | 2019 | 2970 | 0.510 |
Why?
|
| Membrane Microdomains | 7 | 2017 | 61 | 0.490 |
Why?
|
| Obesity | 4 | 2019 | 2378 | 0.480 |
Why?
|
| Blood Glucose | 7 | 2011 | 1102 | 0.470 |
Why?
|
| Water | 2 | 2008 | 190 | 0.470 |
Why?
|
| Diet, High-Fat | 2 | 2016 | 263 | 0.470 |
Why?
|
| Cardiovascular Diseases | 2 | 2025 | 2081 | 0.460 |
Why?
|
| Water-Electrolyte Balance | 4 | 2011 | 81 | 0.460 |
Why?
|
| Erythrocytes | 8 | 2010 | 190 | 0.450 |
Why?
|
| Plasmodium berghei | 7 | 2010 | 14 | 0.450 |
Why?
|
| Homocysteine | 7 | 2017 | 118 | 0.440 |
Why?
|
| Cytoskeletal Proteins | 4 | 2014 | 279 | 0.440 |
Why?
|
| Glucocorticoids | 2 | 2008 | 350 | 0.440 |
Why?
|
| Glomerulosclerosis, Focal Segmental | 1 | 2014 | 33 | 0.430 |
Why?
|
| Oxidation-Reduction | 9 | 2023 | 442 | 0.420 |
Why?
|
| Lipid Metabolism | 3 | 2014 | 371 | 0.410 |
Why?
|
| Proteinuria | 4 | 2017 | 106 | 0.410 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 5 | 2025 | 588 | 0.400 |
Why?
|
| Inflammation | 6 | 2025 | 1488 | 0.400 |
Why?
|
| Kidney Medulla | 3 | 2017 | 19 | 0.390 |
Why?
|
| Plant Extracts | 2 | 2005 | 139 | 0.380 |
Why?
|
| Cystathionine beta-Synthase | 1 | 2012 | 14 | 0.380 |
Why?
|
| Male | 55 | 2018 | 65108 | 0.370 |
Why?
|
| Sodium | 6 | 2011 | 281 | 0.360 |
Why?
|
| Insulin | 5 | 2011 | 1145 | 0.360 |
Why?
|
| Hydrazines | 1 | 2011 | 30 | 0.350 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 8 | 2014 | 1236 | 0.340 |
Why?
|
| Benzamides | 1 | 2011 | 122 | 0.340 |
Why?
|
| Glomerular Mesangium | 1 | 2010 | 19 | 0.330 |
Why?
|
| Kidney Tubules, Proximal | 2 | 2017 | 74 | 0.320 |
Why?
|
| Fructose | 2 | 2011 | 60 | 0.310 |
Why?
|
| Hypothyroidism | 1 | 2010 | 78 | 0.310 |
Why?
|
| Sodium Chloride | 3 | 2017 | 90 | 0.310 |
Why?
|
| Calcium | 7 | 2013 | 1041 | 0.310 |
Why?
|
| Superoxides | 7 | 2014 | 129 | 0.300 |
Why?
|
| Muscle Cells | 3 | 2014 | 25 | 0.300 |
Why?
|
| Hypertension | 6 | 2019 | 1357 | 0.300 |
Why?
|
| Parasitemia | 5 | 2009 | 26 | 0.300 |
Why?
|
| Glycosuria | 1 | 2009 | 6 | 0.300 |
Why?
|
| Malaria | 6 | 2010 | 99 | 0.300 |
Why?
|
| Membrane Proteins | 8 | 2025 | 1614 | 0.290 |
Why?
|
| Permeability | 2 | 2019 | 120 | 0.290 |
Why?
|
| Aldosterone | 5 | 2010 | 58 | 0.280 |
Why?
|
| Glucose | 2 | 2011 | 847 | 0.280 |
Why?
|
| Transfection | 3 | 2016 | 960 | 0.280 |
Why?
|
| Gene Knock-In Techniques | 1 | 2008 | 122 | 0.280 |
Why?
|
| Atherosclerosis | 4 | 2018 | 947 | 0.280 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 1 | 2008 | 50 | 0.270 |
Why?
|
| Diabetic Nephropathies | 1 | 2009 | 114 | 0.270 |
Why?
|
| Cyclooxygenase 2 | 2 | 2019 | 128 | 0.270 |
Why?
|
| Liver | 5 | 2016 | 1794 | 0.270 |
Why?
|
| CARD Signaling Adaptor Proteins | 7 | 2017 | 43 | 0.260 |
Why?
|
| Glomerulonephritis | 3 | 2017 | 75 | 0.260 |
Why?
|
| Steroids | 1 | 2008 | 172 | 0.260 |
Why?
|
| RNA Interference | 7 | 2018 | 496 | 0.260 |
Why?
|
| Verapamil | 2 | 2025 | 48 | 0.260 |
Why?
|
| Hypertension, Renal | 1 | 2006 | 30 | 0.250 |
Why?
|
| Fetal Development | 1 | 2008 | 128 | 0.250 |
Why?
|
| Microscopy, Confocal | 9 | 2015 | 363 | 0.250 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2011 | 617 | 0.250 |
Why?
|
| Body Weight | 6 | 2010 | 986 | 0.240 |
Why?
|
| Diabetes Mellitus | 2 | 2017 | 886 | 0.240 |
Why?
|
| Reactive Oxygen Species | 5 | 2017 | 518 | 0.240 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2008 | 232 | 0.230 |
Why?
|
| Neointima | 2 | 2017 | 46 | 0.230 |
Why?
|
| Eating | 4 | 2009 | 379 | 0.230 |
Why?
|
| Amitriptyline | 2 | 2018 | 27 | 0.230 |
Why?
|
| Vascular Endothelial Growth Factor A | 3 | 2019 | 341 | 0.230 |
Why?
|
| Antidepressive Agents, Tricyclic | 2 | 2018 | 29 | 0.230 |
Why?
|
| Vitis | 1 | 2005 | 14 | 0.220 |
Why?
|
| rac1 GTP-Binding Protein | 2 | 2017 | 64 | 0.220 |
Why?
|
| Nootropic Agents | 1 | 2005 | 27 | 0.220 |
Why?
|
| Membrane Transport Proteins | 1 | 2005 | 185 | 0.210 |
Why?
|
| Gastric Acid | 3 | 2009 | 55 | 0.210 |
Why?
|
| Terminalia | 1 | 2003 | 2 | 0.210 |
Why?
|
| Drinking | 3 | 2009 | 28 | 0.210 |
Why?
|
| RNA, Messenger | 6 | 2018 | 2568 | 0.200 |
Why?
|
| Real-Time Polymerase Chain Reaction | 3 | 2014 | 530 | 0.200 |
Why?
|
| Phytotherapy | 1 | 2003 | 46 | 0.200 |
Why?
|
| Apoptosis | 7 | 2013 | 1862 | 0.200 |
Why?
|
| Caspase Inhibitors | 3 | 2017 | 32 | 0.190 |
Why?
|
| Stress, Physiological | 1 | 2005 | 262 | 0.190 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-1 | 3 | 2017 | 39 | 0.190 |
Why?
|
| Antioxidants | 1 | 2005 | 336 | 0.190 |
Why?
|
| Desoxycorticosterone | 3 | 2012 | 12 | 0.190 |
Why?
|
| Adipose Tissue | 3 | 2017 | 494 | 0.180 |
Why?
|
| Carotid Arteries | 3 | 2017 | 125 | 0.180 |
Why?
|
| Fluorescent Antibody Technique | 3 | 2012 | 420 | 0.180 |
Why?
|
| Macrophages | 2 | 2018 | 663 | 0.180 |
Why?
|
| Biomarkers | 4 | 2025 | 3400 | 0.180 |
Why?
|
| Blotting, Western | 6 | 2014 | 1018 | 0.180 |
Why?
|
| Rats | 11 | 2018 | 3454 | 0.180 |
Why?
|
| Growth Hormone | 2 | 2013 | 127 | 0.180 |
Why?
|
| Hypotension | 1 | 2003 | 184 | 0.180 |
Why?
|
| Kidney Tubules | 3 | 2011 | 77 | 0.180 |
Why?
|
| Sequestosome-1 Protein | 2 | 2018 | 15 | 0.180 |
Why?
|
| Cathepsin B | 2 | 2018 | 9 | 0.180 |
Why?
|
| Angiotensin II | 2 | 2019 | 134 | 0.170 |
Why?
|
| Reserpine | 3 | 2005 | 9 | 0.170 |
Why?
|
| Phosphates | 3 | 2011 | 110 | 0.170 |
Why?
|
| Phagosomes | 3 | 2017 | 37 | 0.160 |
Why?
|
| Fibrosis | 3 | 2017 | 412 | 0.160 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 2 | 2010 | 61 | 0.160 |
Why?
|
| Histone Deacetylase 6 | 1 | 2019 | 8 | 0.160 |
Why?
|
| Butyric Acid | 1 | 2019 | 7 | 0.160 |
Why?
|
| Glucuronidase | 2 | 2010 | 30 | 0.160 |
Why?
|
| Nicotinic Agonists | 1 | 2019 | 33 | 0.160 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2017 | 95 | 0.150 |
Why?
|
| Insulin Resistance | 3 | 2017 | 678 | 0.150 |
Why?
|
| Dinoprostone | 1 | 2019 | 67 | 0.150 |
Why?
|
| Endothelium | 1 | 2019 | 63 | 0.150 |
Why?
|
| Electron Spin Resonance Spectroscopy | 4 | 2013 | 18 | 0.150 |
Why?
|
| Gene Expression Regulation | 5 | 2019 | 2354 | 0.150 |
Why?
|
| Myocytes, Smooth Muscle | 3 | 2018 | 185 | 0.150 |
Why?
|
| Glucose Tolerance Test | 2 | 2010 | 200 | 0.150 |
Why?
|
| Cardiomegaly | 1 | 2019 | 117 | 0.150 |
Why?
|
| Histone Deacetylases | 1 | 2019 | 119 | 0.150 |
Why?
|
| Humans | 24 | 2025 | 131410 | 0.140 |
Why?
|
| Renal Insufficiency, Chronic | 2 | 2017 | 837 | 0.140 |
Why?
|
| Dexamethasone | 3 | 2008 | 260 | 0.140 |
Why?
|
| Matrix Metalloproteinase 12 | 1 | 2018 | 14 | 0.140 |
Why?
|
| Amino Acid Chloromethyl Ketones | 1 | 2017 | 10 | 0.140 |
Why?
|
| Infarction, Middle Cerebral Artery | 1 | 2018 | 37 | 0.140 |
Why?
|
| Procollagen-Proline Dioxygenase | 1 | 2017 | 31 | 0.140 |
Why?
|
| Female | 26 | 2013 | 71030 | 0.140 |
Why?
|
| Hypercholesterolemia | 2 | 2017 | 234 | 0.130 |
Why?
|
| Neovascularization, Physiologic | 1 | 2018 | 204 | 0.130 |
Why?
|
| Proto-Oncogene Proteins c-vav | 1 | 2017 | 11 | 0.130 |
Why?
|
| Creatinine | 3 | 2009 | 399 | 0.130 |
Why?
|
| Vanilmandelic Acid | 3 | 2005 | 8 | 0.130 |
Why?
|
| Valproic Acid | 1 | 2017 | 161 | 0.120 |
Why?
|
| Collagen Type I | 1 | 2017 | 114 | 0.120 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2024 | 833 | 0.120 |
Why?
|
| Hepatic Stellate Cells | 1 | 2016 | 28 | 0.120 |
Why?
|
| Microscopy, Fluorescence | 1 | 2017 | 312 | 0.120 |
Why?
|
| Neuropeptides | 1 | 2017 | 111 | 0.120 |
Why?
|
| Dose-Response Relationship, Drug | 5 | 2010 | 1624 | 0.120 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2013 | 743 | 0.120 |
Why?
|
| DNA Primers | 2 | 2014 | 609 | 0.120 |
Why?
|
| Schistosomiasis | 1 | 2016 | 52 | 0.120 |
Why?
|
| Vacuolar Proton-Translocating ATPases | 2 | 2015 | 24 | 0.120 |
Why?
|
| Sclerosis | 2 | 2012 | 30 | 0.120 |
Why?
|
| Disease Models, Animal | 7 | 2018 | 4683 | 0.120 |
Why?
|
| Myocytes, Cardiac | 2 | 2019 | 672 | 0.110 |
Why?
|
| Arteritis | 1 | 2014 | 7 | 0.110 |
Why?
|
| Biological Transport | 3 | 2012 | 333 | 0.110 |
Why?
|
| Hypophosphatemia, Familial | 2 | 2011 | 2 | 0.110 |
Why?
|
| Enzyme Inhibitors | 1 | 2017 | 566 | 0.110 |
Why?
|
| Rats, Sprague-Dawley | 5 | 2019 | 1148 | 0.110 |
Why?
|
| Energy Intake | 1 | 2017 | 501 | 0.100 |
Why?
|
| Peroxynitrous Acid | 1 | 2013 | 8 | 0.100 |
Why?
|
| Mice, Mutant Strains | 3 | 2009 | 366 | 0.100 |
Why?
|
| Cyclic ADP-Ribose | 1 | 2013 | 1 | 0.100 |
Why?
|
| Hydrogen Peroxide | 1 | 2013 | 117 | 0.100 |
Why?
|
| Simvastatin | 1 | 2013 | 75 | 0.100 |
Why?
|
| TNF-Related Apoptosis-Inducing Ligand | 1 | 2012 | 21 | 0.100 |
Why?
|
| Renin | 1 | 2013 | 76 | 0.100 |
Why?
|
| Base Sequence | 2 | 2014 | 2783 | 0.100 |
Why?
|
| Receptors, TNF-Related Apoptosis-Inducing Ligand | 1 | 2012 | 9 | 0.100 |
Why?
|
| Transient Receptor Potential Channels | 1 | 2013 | 19 | 0.100 |
Why?
|
| Cell Membrane | 2 | 2012 | 464 | 0.100 |
Why?
|
| Mice, Inbred Strains | 3 | 2008 | 297 | 0.100 |
Why?
|
| Desmin | 1 | 2012 | 20 | 0.100 |
Why?
|
| Renal Circulation | 2 | 2013 | 40 | 0.090 |
Why?
|
| Body Temperature | 2 | 2010 | 127 | 0.090 |
Why?
|
| Stem Cells | 1 | 2017 | 712 | 0.090 |
Why?
|
| Cellular Microenvironment | 1 | 2012 | 16 | 0.090 |
Why?
|
| Mesoderm | 1 | 2012 | 107 | 0.090 |
Why?
|
| Plasma Volume | 2 | 2010 | 12 | 0.090 |
Why?
|
| Urodynamics | 2 | 2010 | 37 | 0.090 |
Why?
|
| Glomerular Filtration Rate | 3 | 2013 | 564 | 0.090 |
Why?
|
| Microbubbles | 1 | 2011 | 8 | 0.090 |
Why?
|
| Arterial Pressure | 1 | 2012 | 131 | 0.090 |
Why?
|
| Protein Transport | 4 | 2014 | 362 | 0.090 |
Why?
|
| Membrane Potentials | 2 | 2010 | 297 | 0.090 |
Why?
|
| Corticosterone | 2 | 2008 | 53 | 0.090 |
Why?
|
| Cell Size | 1 | 2011 | 79 | 0.090 |
Why?
|
| NADPH Oxidase 2 | 4 | 2012 | 38 | 0.090 |
Why?
|
| Chromans | 1 | 2010 | 9 | 0.080 |
Why?
|
| Transcriptome | 1 | 2018 | 1162 | 0.080 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2013 | 428 | 0.080 |
Why?
|
| Intermediate-Conductance Calcium-Activated Potassium Channels | 1 | 2010 | 15 | 0.080 |
Why?
|
| Thyrotropin | 1 | 2010 | 54 | 0.080 |
Why?
|
| Parietal Cells, Gastric | 2 | 2008 | 38 | 0.080 |
Why?
|
| Hyperaldosteronism | 1 | 2010 | 18 | 0.080 |
Why?
|
| Triiodothyronine | 1 | 2010 | 56 | 0.080 |
Why?
|
| MicroRNAs | 1 | 2017 | 894 | 0.080 |
Why?
|
| Sodium-Phosphate Cotransporter Proteins, Type IIa | 1 | 2010 | 5 | 0.080 |
Why?
|
| Thyroxine | 1 | 2010 | 62 | 0.080 |
Why?
|
| Homeostasis | 2 | 2011 | 713 | 0.080 |
Why?
|
| Mast Cells | 1 | 2010 | 65 | 0.080 |
Why?
|
| Thyroid Gland | 1 | 2010 | 99 | 0.080 |
Why?
|
| Endothelium, Vascular | 1 | 2013 | 469 | 0.080 |
Why?
|
| Immunohistochemistry | 2 | 2010 | 1610 | 0.080 |
Why?
|
| HeLa Cells | 1 | 2011 | 695 | 0.080 |
Why?
|
| Gene Transfer Techniques | 1 | 2011 | 343 | 0.080 |
Why?
|
| Gene Expression | 4 | 2019 | 1500 | 0.080 |
Why?
|
| Enzyme Activation | 4 | 2012 | 588 | 0.080 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2010 | 133 | 0.080 |
Why?
|
| Hepatocytes | 1 | 2011 | 234 | 0.080 |
Why?
|
| Cadherins | 3 | 2017 | 177 | 0.080 |
Why?
|
| Genotype | 2 | 2013 | 2656 | 0.080 |
Why?
|
| Phosphorylation | 5 | 2011 | 1569 | 0.080 |
Why?
|
| Cell Proliferation | 5 | 2018 | 2464 | 0.080 |
Why?
|
| Flow Cytometry | 5 | 2009 | 769 | 0.080 |
Why?
|
| Chromatography, Liquid | 1 | 2010 | 238 | 0.080 |
Why?
|
| Glucose Transporter Type 1 | 1 | 2009 | 25 | 0.080 |
Why?
|
| Injections, Intraperitoneal | 1 | 2009 | 66 | 0.080 |
Why?
|
| Immunoglobulin E | 1 | 2010 | 225 | 0.080 |
Why?
|
| Hair Follicle | 1 | 2009 | 33 | 0.070 |
Why?
|
| Deoxyglucose | 1 | 2009 | 42 | 0.070 |
Why?
|
| Sodium-Glucose Transporter 1 | 1 | 2009 | 11 | 0.070 |
Why?
|
| Organ Size | 1 | 2010 | 434 | 0.070 |
Why?
|
| Absorption | 1 | 2009 | 50 | 0.070 |
Why?
|
| Adenomatous Polyposis Coli Protein | 1 | 2009 | 26 | 0.070 |
Why?
|
| Sex Characteristics | 2 | 2008 | 336 | 0.070 |
Why?
|
| Antimalarials | 1 | 2009 | 45 | 0.070 |
Why?
|
| Leptin | 1 | 2010 | 218 | 0.070 |
Why?
|
| Chlorpromazine | 1 | 2008 | 12 | 0.070 |
Why?
|
| Time Factors | 4 | 2018 | 6272 | 0.070 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2010 | 173 | 0.070 |
Why?
|
| Hydrogen-Ion Concentration | 4 | 2012 | 426 | 0.070 |
Why?
|
| Biogenic Amines | 2 | 2005 | 17 | 0.070 |
Why?
|
| Paclitaxel | 1 | 2009 | 134 | 0.070 |
Why?
|
| Membrane Fusion | 3 | 2013 | 37 | 0.070 |
Why?
|
| Gum Arabic | 1 | 2008 | 1 | 0.070 |
Why?
|
| Hypokalemia | 1 | 2008 | 40 | 0.070 |
Why?
|
| Hydroxyindoleacetic Acid | 2 | 2005 | 28 | 0.070 |
Why?
|
| Fas Ligand Protein | 3 | 2013 | 36 | 0.070 |
Why?
|
| NG-Nitroarginine Methyl Ester | 1 | 2008 | 57 | 0.070 |
Why?
|
| Homovanillic Acid | 2 | 2005 | 30 | 0.070 |
Why?
|
| Nephrotic Syndrome | 1 | 2008 | 52 | 0.070 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 1 | 2008 | 59 | 0.070 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2010 | 286 | 0.070 |
Why?
|
| Cyclosporine | 1 | 2008 | 129 | 0.070 |
Why?
|
| Hematocrit | 1 | 2008 | 108 | 0.070 |
Why?
|
| Body Size | 1 | 2008 | 59 | 0.070 |
Why?
|
| Gene Knockdown Techniques | 2 | 2019 | 382 | 0.070 |
Why?
|
| Nitric Oxide Synthase | 1 | 2008 | 168 | 0.070 |
Why?
|
| Nitrates | 1 | 2007 | 33 | 0.070 |
Why?
|
| Magnesium | 1 | 2008 | 119 | 0.070 |
Why?
|
| Lead | 1 | 2007 | 24 | 0.070 |
Why?
|
| Avoidance Learning | 2 | 2005 | 63 | 0.070 |
Why?
|
| PPAR gamma | 1 | 2008 | 86 | 0.070 |
Why?
|
| Thiazolidinediones | 1 | 2008 | 79 | 0.070 |
Why?
|
| Caloric Restriction | 1 | 2008 | 106 | 0.070 |
Why?
|
| Doxorubicin | 1 | 2008 | 300 | 0.060 |
Why?
|
| Cell Cycle Proteins | 1 | 2011 | 704 | 0.060 |
Why?
|
| Diet | 2 | 2012 | 1119 | 0.060 |
Why?
|
| Mice, Transgenic | 2 | 2012 | 2363 | 0.060 |
Why?
|
| Muscle, Skeletal | 2 | 2011 | 990 | 0.060 |
Why?
|
| Urine | 1 | 2006 | 92 | 0.060 |
Why?
|
| Animal Feed | 1 | 2006 | 76 | 0.060 |
Why?
|
| Dietary Proteins | 1 | 2008 | 215 | 0.060 |
Why?
|
| Colonic Neoplasms | 1 | 2009 | 266 | 0.060 |
Why?
|
| Calcitriol | 3 | 2011 | 62 | 0.060 |
Why?
|
| Parathyroid Hormone | 3 | 2011 | 76 | 0.060 |
Why?
|
| Cattle | 3 | 2012 | 521 | 0.060 |
Why?
|
| Models, Biological | 1 | 2011 | 1390 | 0.060 |
Why?
|
| Infertility, Female | 1 | 2007 | 153 | 0.060 |
Why?
|
| Water Deprivation | 1 | 2005 | 4 | 0.060 |
Why?
|
| Antidiuretic Hormone Receptor Antagonists | 1 | 2005 | 4 | 0.060 |
Why?
|
| NADP | 2 | 2017 | 54 | 0.060 |
Why?
|
| Gastric Mucosa | 1 | 2009 | 489 | 0.060 |
Why?
|
| Age Factors | 2 | 2009 | 2869 | 0.060 |
Why?
|
| Renal Insufficiency | 1 | 2008 | 250 | 0.060 |
Why?
|
| Iodides | 1 | 2005 | 11 | 0.060 |
Why?
|
| Drug Synergism | 1 | 2005 | 239 | 0.060 |
Why?
|
| Extracellular Space | 2 | 2019 | 83 | 0.060 |
Why?
|
| Kidney Function Tests | 1 | 2005 | 136 | 0.060 |
Why?
|
| Hypoglycemia | 1 | 2006 | 181 | 0.060 |
Why?
|
| Fertility | 1 | 2007 | 264 | 0.060 |
Why?
|
| Calcium-Binding Proteins | 2 | 2018 | 328 | 0.060 |
Why?
|
| Ascorbic Acid | 1 | 2005 | 71 | 0.050 |
Why?
|
| Fluid Therapy | 1 | 2005 | 145 | 0.050 |
Why?
|
| Seeds | 1 | 2005 | 42 | 0.050 |
Why?
|
| Colforsin | 3 | 2009 | 46 | 0.050 |
Why?
|
| beta Catenin | 3 | 2011 | 209 | 0.050 |
Why?
|
| Actins | 2 | 2017 | 317 | 0.050 |
Why?
|
| Proteolysis | 2 | 2017 | 189 | 0.050 |
Why?
|
| Endometrium | 1 | 2007 | 291 | 0.050 |
Why?
|
| Pyrilamine | 1 | 2003 | 1 | 0.050 |
Why?
|
| Plant Bark | 1 | 2003 | 4 | 0.050 |
Why?
|
| Medicine, Ayurvedic | 1 | 2003 | 5 | 0.050 |
Why?
|
| Atropine | 1 | 2003 | 30 | 0.050 |
Why?
|
| Phosphatidylserines | 3 | 2008 | 46 | 0.050 |
Why?
|
| Hypoglycemic Agents | 1 | 2008 | 469 | 0.050 |
Why?
|
| Zonula Occludens-1 Protein | 2 | 2015 | 17 | 0.050 |
Why?
|
| Matrix Metalloproteinase 9 | 2 | 2017 | 139 | 0.050 |
Why?
|
| Injections, Intravenous | 1 | 2003 | 242 | 0.050 |
Why?
|
| Chromatography, Gel | 2 | 2014 | 78 | 0.050 |
Why?
|
| Propranolol | 1 | 2003 | 110 | 0.050 |
Why?
|
| Phosphoproteins | 2 | 2018 | 435 | 0.050 |
Why?
|
| Lysosomal-Associated Membrane Protein 1 | 2 | 2013 | 15 | 0.050 |
Why?
|
| Plasmodium falciparum | 3 | 2008 | 96 | 0.050 |
Why?
|
| Lipids | 1 | 2006 | 566 | 0.050 |
Why?
|
| Dogs | 1 | 2003 | 621 | 0.050 |
Why?
|
| Behavior, Animal | 1 | 2005 | 509 | 0.050 |
Why?
|
| Sirolimus | 2 | 2013 | 231 | 0.040 |
Why?
|
| Adaptation, Psychological | 1 | 2005 | 434 | 0.040 |
Why?
|
| Antipsychotic Agents | 1 | 2005 | 379 | 0.040 |
Why?
|
| Vasodilator Agents | 2 | 2014 | 201 | 0.040 |
Why?
|
| Lung | 1 | 2009 | 1565 | 0.040 |
Why?
|
| Phenotype | 3 | 2018 | 4516 | 0.040 |
Why?
|
| Calcium Signaling | 2 | 2013 | 249 | 0.040 |
Why?
|
| Patch-Clamp Techniques | 2 | 2010 | 279 | 0.040 |
Why?
|
| Intercellular Junctions | 1 | 2019 | 25 | 0.040 |
Why?
|
| Cell Hypoxia | 2 | 2009 | 86 | 0.040 |
Why?
|
| Tight Junctions | 1 | 2019 | 39 | 0.040 |
Why?
|
| Folic Acid | 2 | 2012 | 286 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-sis | 1 | 2018 | 18 | 0.040 |
Why?
|
| Analysis of Variance | 2 | 2014 | 954 | 0.040 |
Why?
|
| Chalcones | 1 | 2018 | 5 | 0.040 |
Why?
|
| Losartan | 1 | 2018 | 35 | 0.040 |
Why?
|
| Cell Membrane Permeability | 1 | 2018 | 67 | 0.040 |
Why?
|
| Up-Regulation | 2 | 2014 | 832 | 0.040 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2019 | 140 | 0.040 |
Why?
|
| Omeprazole | 2 | 2009 | 100 | 0.040 |
Why?
|
| Carbachol | 2 | 2008 | 14 | 0.040 |
Why?
|
| Myofibroblasts | 1 | 2018 | 62 | 0.040 |
Why?
|
| Recombinant Proteins | 2 | 2013 | 1312 | 0.040 |
Why?
|
| Cell Death | 2 | 2009 | 237 | 0.040 |
Why?
|
| S100 Calcium-Binding Protein A4 | 1 | 2017 | 21 | 0.030 |
Why?
|
| Hypoxia-Inducible Factor-Proline Dioxygenases | 1 | 2017 | 20 | 0.030 |
Why?
|
| Rats, Inbred Dahl | 1 | 2017 | 6 | 0.030 |
Why?
|
| AC133 Antigen | 1 | 2017 | 35 | 0.030 |
Why?
|
| Albumins | 1 | 2017 | 92 | 0.030 |
Why?
|
| Phagocytosis | 1 | 2018 | 191 | 0.030 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2017 | 49 | 0.030 |
Why?
|
| Species Specificity | 1 | 2018 | 519 | 0.030 |
Why?
|
| Diet, Western | 1 | 2017 | 20 | 0.030 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2018 | 230 | 0.030 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2018 | 240 | 0.030 |
Why?
|
| Proteasome Inhibitors | 1 | 2017 | 57 | 0.030 |
Why?
|
| Cell Differentiation | 2 | 2015 | 1945 | 0.030 |
Why?
|
| Schistosoma | 1 | 2016 | 13 | 0.030 |
Why?
|
| Celecoxib | 1 | 2016 | 34 | 0.030 |
Why?
|
| Antigens | 1 | 2016 | 149 | 0.030 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 1 | 2016 | 47 | 0.030 |
Why?
|
| Forkhead Transcription Factors | 2 | 2009 | 371 | 0.030 |
Why?
|
| Nitric Oxide | 1 | 2018 | 465 | 0.030 |
Why?
|
| Macrolides | 1 | 2015 | 31 | 0.030 |
Why?
|
| Pregnancy | 1 | 2008 | 7571 | 0.030 |
Why?
|
| CDC2 Protein Kinase | 1 | 2015 | 36 | 0.030 |
Why?
|
| Unfolded Protein Response | 1 | 2015 | 62 | 0.030 |
Why?
|
| Cell Wall | 1 | 2014 | 42 | 0.030 |
Why?
|
| Free Radical Scavengers | 1 | 2014 | 56 | 0.030 |
Why?
|
| Blood Flow Velocity | 1 | 2016 | 425 | 0.030 |
Why?
|
| Potassium Channel Blockers | 1 | 2014 | 84 | 0.030 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2014 | 71 | 0.030 |
Why?
|
| Mitosis | 1 | 2015 | 191 | 0.030 |
Why?
|
| Survival Analysis | 2 | 2008 | 1522 | 0.030 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2015 | 124 | 0.030 |
Why?
|
| Azo Compounds | 1 | 2014 | 12 | 0.030 |
Why?
|
| Mice, Obese | 1 | 2014 | 73 | 0.030 |
Why?
|
| Ubiquitinated Proteins | 1 | 2013 | 3 | 0.030 |
Why?
|
| Mutation | 1 | 2008 | 6177 | 0.030 |
Why?
|
| Transcription Factor TFIIH | 1 | 2013 | 6 | 0.030 |
Why?
|
| Adenosine Diphosphate Ribose | 1 | 2013 | 7 | 0.030 |
Why?
|
| Cathepsins | 1 | 2014 | 26 | 0.030 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2015 | 131 | 0.030 |
Why?
|
| Ligation | 1 | 2014 | 136 | 0.030 |
Why?
|
| Transforming Growth Factor beta | 1 | 2017 | 463 | 0.030 |
Why?
|
| Aorta, Thoracic | 1 | 2018 | 536 | 0.030 |
Why?
|
| Cyclic N-Oxides | 1 | 2013 | 18 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 1 | 2016 | 1022 | 0.030 |
Why?
|
| Spin Labels | 1 | 2013 | 25 | 0.030 |
Why?
|
| Catalase | 1 | 2013 | 64 | 0.030 |
Why?
|
| Autophagy-Related Protein 7 | 1 | 2013 | 12 | 0.030 |
Why?
|
| Microvessels | 1 | 2014 | 65 | 0.030 |
Why?
|
| Oligopeptides | 1 | 2014 | 123 | 0.020 |
Why?
|
| ADP-ribosyl Cyclase | 1 | 2013 | 4 | 0.020 |
Why?
|
| Survival Rate | 2 | 2008 | 2146 | 0.020 |
Why?
|
| G(M1) Ganglioside | 1 | 2012 | 9 | 0.020 |
Why?
|
| Tunica Intima | 1 | 2013 | 57 | 0.020 |
Why?
|
| Escherichia coli | 1 | 2018 | 984 | 0.020 |
Why?
|
| fas Receptor | 1 | 2013 | 43 | 0.020 |
Why?
|
| Isoproterenol | 1 | 2013 | 89 | 0.020 |
Why?
|
| Calpain | 1 | 2013 | 41 | 0.020 |
Why?
|
| NF-kappa B | 1 | 2015 | 448 | 0.020 |
Why?
|
| Adrenergic beta-Agonists | 1 | 2013 | 79 | 0.020 |
Why?
|
| Adenine | 1 | 2013 | 124 | 0.020 |
Why?
|
| Fluorescence Resonance Energy Transfer | 1 | 2012 | 72 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2017 | 1231 | 0.020 |
Why?
|
| Sarcoplasmic Reticulum | 1 | 2013 | 149 | 0.020 |
Why?
|
| Phosphatidylinositol Phosphates | 1 | 2012 | 25 | 0.020 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2012 | 134 | 0.020 |
Why?
|
| Oxygen Consumption | 1 | 2013 | 301 | 0.020 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2013 | 251 | 0.020 |
Why?
|
| Mice, 129 Strain | 1 | 2011 | 97 | 0.020 |
Why?
|
| Neurodegenerative Diseases | 1 | 2015 | 289 | 0.020 |
Why?
|
| Microfilament Proteins | 1 | 2013 | 272 | 0.020 |
Why?
|
| Cell Line, Transformed | 1 | 2011 | 160 | 0.020 |
Why?
|
| Glucose Intolerance | 1 | 2011 | 78 | 0.020 |
Why?
|
| Phenylhydrazines | 1 | 2010 | 2 | 0.020 |
Why?
|
| Dizocilpine Maleate | 1 | 2010 | 16 | 0.020 |
Why?
|
| Diffusion Chambers, Culture | 1 | 2010 | 6 | 0.020 |
Why?
|
| Matrix Metalloproteinase 1 | 1 | 2010 | 23 | 0.020 |
Why?
|
| N-Methylaspartate | 1 | 2010 | 30 | 0.020 |
Why?
|
| Survival | 1 | 2010 | 15 | 0.020 |
Why?
|
| beta-N-Acetylhexosaminidases | 1 | 2010 | 9 | 0.020 |
Why?
|
| Anemia, Hemolytic | 1 | 2010 | 30 | 0.020 |
Why?
|
| Ear | 1 | 2010 | 27 | 0.020 |
Why?
|
| Hemolysin Proteins | 1 | 2010 | 29 | 0.020 |
Why?
|
| Vasopressins | 1 | 2010 | 44 | 0.020 |
Why?
|
| Adrenocorticotropic Hormone | 1 | 2010 | 64 | 0.020 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 1 | 2013 | 241 | 0.020 |
Why?
|
| Cell Degranulation | 1 | 2010 | 28 | 0.020 |
Why?
|
| Pancreas | 1 | 2011 | 218 | 0.020 |
Why?
|
| Hemolysis | 1 | 2010 | 86 | 0.020 |
Why?
|
| Aminoimidazole Carboxamide | 1 | 2010 | 18 | 0.020 |
Why?
|
| Calcification, Physiologic | 1 | 2010 | 24 | 0.020 |
Why?
|
| Enzyme Activators | 1 | 2010 | 11 | 0.020 |
Why?
|
| Ion Transport | 1 | 2010 | 48 | 0.020 |
Why?
|
| Insulin-Secreting Cells | 1 | 2011 | 136 | 0.020 |
Why?
|
| Filipin | 1 | 2009 | 2 | 0.020 |
Why?
|
| Microvilli | 1 | 2010 | 65 | 0.020 |
Why?
|
| Cell Movement | 1 | 2014 | 875 | 0.020 |
Why?
|
| Blood Chemical Analysis | 1 | 2010 | 83 | 0.020 |
Why?
|
| beta-Cyclodextrins | 1 | 2009 | 12 | 0.020 |
Why?
|
| Xenopus | 1 | 2010 | 103 | 0.020 |
Why?
|
| Feedback, Physiological | 1 | 2010 | 67 | 0.020 |
Why?
|
| Ribonucleotides | 1 | 2010 | 31 | 0.020 |
Why?
|
| Adiponectin | 1 | 2010 | 124 | 0.020 |
Why?
|
| Coronary Artery Disease | 1 | 2017 | 865 | 0.020 |
Why?
|
| Vasodilation | 1 | 2010 | 174 | 0.020 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2009 | 122 | 0.020 |
Why?
|
| Bcl-2-Like Protein 11 | 1 | 2009 | 14 | 0.020 |
Why?
|
| 1,2-Dimethylhydrazine | 1 | 2009 | 6 | 0.020 |
Why?
|
| Bacterial Toxins | 1 | 2010 | 171 | 0.020 |
Why?
|
| Sebaceous Glands | 1 | 2009 | 3 | 0.020 |
Why?
|
| Forkhead Box Protein O3 | 1 | 2009 | 31 | 0.020 |
Why?
|
| Mitochondria | 1 | 2015 | 759 | 0.020 |
Why?
|
| Cholesterol, LDL | 1 | 2013 | 612 | 0.020 |
Why?
|
| Extracellular Matrix | 1 | 2010 | 230 | 0.020 |
Why?
|
| Annexin A5 | 1 | 2009 | 18 | 0.020 |
Why?
|
| Muscle Proteins | 1 | 2012 | 401 | 0.020 |
Why?
|
| Liver Cirrhosis | 1 | 2016 | 900 | 0.020 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 2008 | 59 | 0.020 |
Why?
|
| Bone Marrow Cells | 1 | 2010 | 245 | 0.020 |
Why?
|
| Keratinocytes | 1 | 2009 | 74 | 0.020 |
Why?
|
| Quaternary Ammonium Compounds | 1 | 2008 | 37 | 0.020 |
Why?
|
| 3-Phosphoinositide-Dependent Protein Kinases | 1 | 2008 | 18 | 0.020 |
Why?
|
| Isoquinolines | 1 | 2008 | 42 | 0.020 |
Why?
|
| Erythrocyte Membrane | 1 | 2008 | 19 | 0.020 |
Why?
|
| Oxygen | 1 | 2012 | 552 | 0.020 |
Why?
|
| Bone Density | 1 | 2011 | 363 | 0.020 |
Why?
|
| Morphogenesis | 1 | 2009 | 194 | 0.020 |
Why?
|
| Mineralocorticoids | 1 | 2008 | 4 | 0.020 |
Why?
|
| Epithelial Sodium Channels | 1 | 2008 | 16 | 0.020 |
Why?
|
| Albuminuria | 1 | 2008 | 106 | 0.020 |
Why?
|
| Erythrocyte Count | 1 | 2007 | 23 | 0.020 |
Why?
|
| Reticulocytes | 1 | 2007 | 29 | 0.020 |
Why?
|
| Dietary Fiber | 1 | 2008 | 78 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2009 | 989 | 0.020 |
Why?
|
| In Vitro Techniques | 1 | 2009 | 824 | 0.020 |
Why?
|
| Urea | 1 | 2008 | 226 | 0.020 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2008 | 300 | 0.020 |
Why?
|
| Urinalysis | 1 | 2008 | 73 | 0.020 |
Why?
|
| Prediabetic State | 1 | 2008 | 66 | 0.020 |
Why?
|
| Prolactin | 1 | 2007 | 112 | 0.020 |
Why?
|
| Menstrual Cycle | 1 | 2007 | 35 | 0.020 |
Why?
|
| Forkhead Box Protein O1 | 1 | 2007 | 103 | 0.020 |
Why?
|
| Staphylococcus aureus | 1 | 2010 | 485 | 0.020 |
Why?
|
| Microarray Analysis | 1 | 2007 | 226 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2008 | 410 | 0.020 |
Why?
|
| Sulfonamides | 1 | 2008 | 296 | 0.020 |
Why?
|
| Spironolactone | 1 | 2006 | 22 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2008 | 722 | 0.020 |
Why?
|
| Decidua | 1 | 2007 | 147 | 0.020 |
Why?
|
| Hemodynamics | 1 | 2010 | 816 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2009 | 600 | 0.010 |
Why?
|
| Immobility Response, Tonic | 1 | 2005 | 2 | 0.010 |
Why?
|
| Stromal Cells | 1 | 2007 | 314 | 0.010 |
Why?
|
| Organ Specificity | 1 | 2006 | 400 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2009 | 1488 | 0.010 |
Why?
|
| Norepinephrine | 1 | 2005 | 156 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2008 | 1087 | 0.010 |
Why?
|
| Weight Loss | 1 | 2008 | 513 | 0.010 |
Why?
|
| Rats, Wistar | 1 | 2005 | 307 | 0.010 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2006 | 344 | 0.010 |
Why?
|
| Feces | 1 | 2008 | 725 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2005 | 333 | 0.010 |
Why?
|
| Serotonin | 1 | 2005 | 212 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2013 | 2436 | 0.010 |
Why?
|
| Dopamine | 1 | 2005 | 256 | 0.010 |
Why?
|
| Motor Activity | 1 | 2005 | 508 | 0.010 |
Why?
|
| Anesthesia | 1 | 2004 | 210 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2009 | 2566 | 0.010 |
Why?
|
| Adult | 1 | 2007 | 31628 | 0.000 |
Why?
|